RxDoctor Payments Data

Emil Ganjian, MD

Otolaryngology/Facial Plastic Surgery · Mineola, NYNPI 1902824782

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Neurent Medical Limited at 42.0% of the total. Reporting peaked in 2023 at $754 and has fallen 82.3% since, to $133 in 2025. That places this record below the midpoint for otolaryngology/facial plastic surgery clinicians in NY, where the typical reported total is $2,391.

$1,853in general payments, 2019–2025

Across 22 payments — averaging $84.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurent Medical Limited$779
  • Intersect ENT, Inc.$310
  • Acclarent, Inc$184
  • Stryker$176
  • Inspire Medical Systems, Inc.$150
  • Integra Lifesciences Corporation$133
  • plus $122 from 1 others

What the payments were for

  • Food & beverage$1,853100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,853 in reported general payments places this provider in the 40th percentile of 48 otolaryngology/facial plastic surgery providers in New York.

See all otolaryngology/facial plastic surgery providers in New York

Medicare billing

Part B allowed, 2024
$387,338
Medicare patients
698
Services billed
2,533

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate508$6,499
Azelastine Hcl177$3,757
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth13$1,458
Levocetirizine Dihydrochloride137$1,195
Mometasone Furoate38$1,134
Famotidine132$782
Montelukast Sodium94$518
Ipratropium Bromide20$437
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav55$428
Omeprazole55$361
Prednisone114$264
Methylprednisolone30$203
Doxycycline Monohydrate18$199
Mupirocin33$195

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Mineola

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →